AI News Sentiment & Analysis
HeartBeam, Inc. (BEAT) — AI News Sentiment & Analysis
4 recent AI analyses of HeartBeam, Inc. (BEAT) stock news and press releases, with sentiment and confidence scoring updated continuously.
HeartBeam (BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection
BullishEnrollment of first patients in the ALIGN-ACS pilot study for heart attack detection. (Timing: Ongoing study with medium-term data generation expected.)Mar 5, 2026HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study
BullishFirst patient enrollments in the ALIGN-ACS pilot study for heart attack detection technology. (Timing: Within 6 months)Mar 5, 2026HeartBeam (BEAT) Announces Commercial Partnership With ClearCardio
BullishCommercial partnership with ClearCardio to deploy HeartBeam's ECG technology. (Timing: Immediate rollout with staged implementation.)Mar 4, 2026HeartBeam (BEAT) Upgraded to Buy as New Joseph Gunnar Report Raises Price Target
BullishFDA clearance of HeartBeam's 12-lead ECG system and Joseph Gunnar's raised price target. (Timing: Within 12 months)Mar 4, 2026
Want the full picture?
These are AI-read press-release catalysts. Sign up to see complete investment theses, valuation rationales, entry/exit strategies, and get real-time alerts.
Sign Up for FreeFrequently Asked Questions
Is HeartBeam, Inc. (BEAT) bullish or bearish right now?
AI Sentiment on BEAT: 4 Bullish.
What was the latest AI analysis for HeartBeam, Inc. (BEAT)?
The latest analysis was published on 3/5/2026 with the headline: "HeartBeam (BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection".
How does Bekodia analyze HeartBeam, Inc. (BEAT) stock?
Bekodia uses advanced AI models to process HeartBeam, Inc. (BEAT) press releases and news in real-time, extracting sentiment, confidence scores, and key investment catalysts while filtering out market noise.